+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Drugs By Therapeutic Area Market Research Reports

From
From
From
From
From
From
From
From
Analgesics in Brazil - Product Thumbnail Image

Analgesics in Brazil

  • Report
  • December 2025
  • 26 Pages
  • Brazil
From
Sleep Aids in Brazil - Product Thumbnail Image

Sleep Aids in Brazil

  • Report
  • December 2025
  • 23 Pages
  • Brazil
From
Dermatologicals in Brazil - Product Thumbnail Image

Dermatologicals in Brazil

  • Report
  • December 2025
  • 26 Pages
  • Brazil
From
Analgesics in Algeria - Product Thumbnail Image

Analgesics in Algeria

  • Report
  • December 2025
  • 21 Pages
  • Algeria
From
Dermatologicals in Algeria - Product Thumbnail Image

Dermatologicals in Algeria

  • Report
  • December 2025
  • 20 Pages
  • Algeria
From
Analgesics in Tunisia - Product Thumbnail Image

Analgesics in Tunisia

  • Report
  • November 2025
  • 21 Pages
  • Tunisia
From
Analgesics in the Philippines - Product Thumbnail Image

Analgesics in the Philippines

  • Report
  • November 2025
  • 24 Pages
  • Philippines
From
Sleep Aids in the Philippines - Product Thumbnail Image

Sleep Aids in the Philippines

  • Report
  • November 2025
  • 22 Pages
  • Philippines
From
Dermatologicals in the Philippines - Product Thumbnail Image

Dermatologicals in the Philippines

  • Report
  • November 2025
  • 24 Pages
  • Philippines
From
From
From
From
Loading Indicator

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more